Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Retatrutide Peptide: Benefits, Uses, Side Effects, Dosage, and Research
Anjana RM, Kesavadev J, Neeta D et al (2017) A multicenter real-life study on the effect of flash glucose monitoring on glycemic control in patients with type 1 and type 2 diabetes
Try to avoid commercial instant sachets with added sugar or flavouring
Exendin-4 is a 39 amino acid peptide with 53% identity to GLP-1 (34) and is fully active at GLP-1 receptors and not degraded by DPP-4
What Recent Research and Regulatory Updates Show A 2024 Danish study found that adults with type 2 diabetes who used semaglutide once a week were more than twice as likely to develop NAION within five years compared with non-users (HR 2.19), with a median onset of 22 months after starting the medication